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Introduction: Unfamiliarity with certain clinical presentations, as illustrated in these cases, can lead to delayed
diagnoses that in turn cause increased morbidity, prolonged hospitalization, and the need for autopsy.
Case presentation: In Case 1, a 63-year-old Caucasian woman presented with hepatic enlargement and
insufficiency which progressed and resulted in her death over a period of less than 2 weeks. The patient underwent
a detailed workup included magnetic resonance imaging and computed tomography scan of her liver, which did
not reveal the source of her liver enlargement. Due to her progressive liver enlargement and insufficiency, she
developed a life-threatening esophageal variceal bleeding during her hospital stay which further delayed the
attainment of her diagnosis. She finally underwent a videoscopic laparotomy and liver biopsy which revealed
complete replacement and filling in of the liver sinuous with Indian filing lobular breast cancer. The patient died
shortly after her diagnosis and before she could be discharged.
In Case 2, a 68-year-old Caucasian woman with non-small-cell lung cancer was admitted to our Oncology in-patient
service with a presentation of rapid hepatic insufficiency and severe liver enlargement. Like the patient in Case 1,
during her hospitalization, this patient underwent a thorough radiographic evaluation, including computed
tomography and magnetic resonance imaging, to identify the source of her symptoms. Radiographic imaging
showed only hepatomegaly and no discrete focal lesions. As the multiple imaging studies over a period of a week
did not reveal a clear cause for her symptoms, she finally underwent an interventional radiology core biopsy which
showed complete replacement of her liver with non-small-cell lung cancer. Her condition rapidly progressed due to
continued liver enlargement and she died due to frank liver failure before her diagnosis was affirmed and she
could be discharged.
Conclusion: Both of these cases illustrate the potential difficulties in diagnosing liver-infiltrative malignancy and the
need for a high index of clinical suspicion for occult infiltrative malignancy in the liver to determine the appropriate
therapeutic intervention, including further treatment of malignancy, palliative care, or determination of candidacy
for liver transplantation. Because the diagnosis for the cause of symptoms and hepatomegaly was elucidated only
by liver biopsy which occurred much later in their hospital course, both patients died while in the hospital instead
of at home or in a hospice. Moreover, these delays in diagnosis and development of morbidities due to the
progressing liver failure further prevent any possibility of early initiation of palliative treatment. Initial recognition of
this type of presentation can lead to a prompt diagnostic biopsy and diagnosis. Giving the patient a correct
diagnosis is one of the fundamental goals of oncology: a goal that, as illustrated in literature review, is not always
achieved. Although treatment options in such cases often may be limited, prompt discharge from the hospital and/or
admission into a hospice program can potentially afford the patient the best quality of life and help protect the
patient’s dignity.* Correspondence: dnreisman@ufl.edu
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Lung and breast cancer are common cancers that typic-
ally present with a dominant primary lesion and metas-
tasis to one of several places, most commonly the brain,
bone, liver, and the adrenal glands. Common cancers
such as breast or lung present more frequently in an
atypical manner than the presentation of an atypical or
rare disease. As such, it sometimes takes a high index of
suspicion to diagnose these cancers. When these cancers
metastasize to other organs, they tend to form discrete
lesions that are easily identified by standard radiographic
methods, including magnetic resonance imaging (MRI)
and computed tomography (CT). However, when the
tumor radiographically blends with the normal organ
parenchyma, the diagnosis of metastatic disease or re-
currence can be difficult. Thus, extensive workup can
ensue until a tissue biopsy is obtained. When the organ
involved is the liver, the potential for bleeding post-
procedure may make the physician disinclined to pursue
the biopsy. In this report, we describe two cases involv-
ing a 63-year-old Caucasian woman and a 68-year-old
Caucasian woman presenting with radiological occult
metastasis to the liver to illustrate this point.Case presentations
Case 1
A 68-year-old Caucasian patient with a history of breast
cancer initially diagnosed 7 years prior was admitted to
our Oncology service with worsening abdominal disten-
sion. She had had a mastectomy and radiation for local
invasive lobular breast cancer 4 years prior, as well as
elevation in liver function tests, including aspartate ami-
notransferase (AST) 150IU/L, alanine aminotransferase
(ALT) 233IU/L, alkaline phosphatase of 734IU/L, and
bilirubin of 3.4mg/dL. She first had an abdominal CT
that showed a significantly enlarged liver, ascites, and no
adenopathy or metastasis. An MRI of the liver also
showed that the liver was essentially homogenous, with
no focal lesions visible.
The patient underwent paracentesis, from which the
ascites appeared to be transudative, with no cancer or
infectious etiology found. In her third hospital day, she
suffered an acute esophageal variceal bleed that
prompted her to be admitted to the Intensive Care Unit
(ICU) for urgent endoscopy and cauterization. When
she returned to the floor, she then underwent a laparo-
scopic biopsy of the liver that showed infiltrating lobular
breast cancer. Lobular carcinoma of the breast is known
to grow in a so-called ‘Indian file’ pattern (single rows
of cells rather than large clusters or glands). In this
case, the tumor was found within vessels and liver sinu-
soids, giving a homogenous appearance to the patient’s
prior imaging studies. The patient died shortly afterdiagnosis and less than 2 weeks after being admitted
with liver failure.
Case 2
The patient was a 63-year-old Caucasian woman who
was initially diagnosed with Stage IIIA adenocarcinoma
of the lung. Over the next 4 months, she underwent six
cycles of cisplatin and etoposide. Two weeks later, her
positron emission tomography (PET)-CT scan showed
some mild progression of primary right upper lobe
lesions as well as increased supraclavicular lymphaden-
opathy on the left lobe. The CT scan at that time
showed a normal-sized liver, with the size measured at
13cm from dome to tip and a volume of 1194cc.
Four weeks after completing her chemotherapy, she
presented to the Emergency department with a two-
week history of rapidly worsening right upper quadrant
pain and abdominal distension. She reported that it had
hurt to cough or sneeze for that period of time. In the
Emergency department, her liver enzymes were noted to
be moderately elevated at aspartate aminotransferase
(AST) 223IU/L, alanine aminotransferase (ALT) 156IU/L,
alkaline phosphatase 883IU/L, lipase 20IU/L, total biliru-
bin 1.6mg/dL, and direct bilirubin 0.8mg/dL. On physical
examination, the patient was extremely sensitive to palpa-
tion or percussion over the right upper quadrant and
along her lower right ribs. Her liver was palpable 4 to 5cm
below the costal margin in the midline. Her physical
examination showed no signs of splenomegaly, caput me-
dusae, hemorrhoid, or spider angiomas on her chest or
neck. Her sclera was anicteric; her examination was other-
wise unremarkable.
A CT scan performed in the Emergency department
prior to admission, as detailed in Figure 1 (notably, less
than 1 month after her prior scan) showed enlargement
of both lobes of her liver; the liver was described as hav-
ing a homogenous texture and no focal metastasis. Specif-
ically, her liver on this CT study showed an impressive
increase in size from 13cm to 18cm from dome to tip
with a corresponding increase from 1194cc to 2655cc,
which occurred over a 4-week period. Additionally, there
was a rim of fluid between the capsule of the liver and
parenchyma. Her gallbladder had been surgically
removed. The patient was admitted to the Oncology ser-
vice for further workup of the specific cause of her ab-
dominal pain and to plan for pain control. She underwent
a PET scan (panels C and D of Figure 1), which showed
no areas of specific uptake indicating metastatic lesions.
Given the homogeneity of the liver as evidenced by
the CT scan, the patient underwent CT-guided liver bi-
opsy, which showed diffuse infiltration by adenocarcin-
oma (Figure 2). Tumor cells showed strong nuclear
expression of thyroid transcription factor-1, cytoplasmic
expression of cytokeratin (CK)7, and were negative for
Figure 1 Case 2: Computed tomography (CT) and positron emission tomography. Panel A: Computed tomography of the chest shows the
primary lesion in the right upper lobe caused by partial obstruction of the right upper lobe bronchus. Panel B: The CT scan of the liver shows
essentially a normal-appearing liver without focal infiltrates present. Panel C: Positron emission tomography scan of the primary lesion shows
intense fluorodeoxyglucose (FDG) uptake with some uptake noted in lymph nodes. Panel D: The right lobe of the liver looks normal, whereas the
left lobe shows diffuse low FDG uptake suggestive of a pathological process. Panel E: A homogenous liver.
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interest, the biopsy only showed a small amount of unin-
volved liver parenchyma, and the tumor cells demon-
strated frequent mitotic figures, attesting to rapid cancer
growth illustrated with the gross enlargement of the
patient’s liver that had occurred over this 4-week period.
With this significant finding on tissue biopsy, focus
shifted to a palliative approach with control of pain in
accordance with the patient’s wishes and given the futil-
ity of treatment due to the worsening hepatic failure.
The patient died on the fourth day of hospital admission
before her diagnosis could be affirmed because of the
significant involvement of the liver parenchyma by her
malignancy.
Discussion
When a CT scan does not reveal overt signs of meta-
static disease but rather a homogeneously appearingliver, as noted in both cases, it is important to have a
high index of suspicion for infiltrating cancer. Delays in
diagnosis can lead to additional morbidity and mortality
if therapy is not initiated early enough. Because the pa-
tient in Case 2 had an active cancer, it was more obvious
that her liver was impacted by the spread of her disease.
However, Case 1 points to the difficulty that occurs
when the history of cancer is not necessarily recent. In
these cases, it is much harder to diagnose the cause of
the liver enlargement, short of a biopsy. In both cases,
the patients had poor performance status upon presenta-
tion due to the stretching of the liver capsule, resulting
in anorexia and weight loss, and progressed rapidly to
death. The condition of these patients therefore essen-
tially prevented therapeutic interventions from being
pursued. Both cases illustrate the lethality of these diag-
noses and the need for prompt recognition to institute a
palliative-focused approach if clinically appropriate.
Figure 2 Case 2: Core biopsy for the liver of a 63-year-old patient with a rapidly enlarging liver. Panel A: Liver biopsy with metastatic
adenocarcinoma. Liver tissue (top left) is diffusely infiltrated by malignant cells (bottom right) (hematoxylin-eosin stain; 10×). Panel B: Case 2:
High-power view of tumor cells with a high nuclear-to-cytoplasmic ratio, prominent nucleoli, and frequent mitosis (black circles) (hematoxylin-
eosin stain; 40×).
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focal lesions noted on standard imaging with CT and
MRI. The differential diagnosis for an infiltrative liver
process is broad and includes fatty infiltration, drug-
induced hepatitis, and viral hepatitis. However, in the two
cases described above, metastatic disease may present as
an infiltrating malignancy without any focal lesions on
radiographic imaging and must be considered in all
patients presenting with occult hepatic insufficiency.
Review of the literature does describe malignancies
that may present in this manner, although the cases are
somewhat infrequent; Table 1 lists a summary of the
cases found in the literature. Allison et al. described
three cases in which infiltrative cancer was identified
only at autopsy, which reinforces both the severity of
these manifestations and the need for a high index of
suspicion for this type of clinical presentation [1]. Two
of these cases were infiltrating ductal carcinoma of the
breast that presented with new-onset liver failure, but
radiologic imaging failed to delineate any hepatic metas-
tases. The third case had no history of carcinoma and
presented with a severe thrombocytopenic purpura-like
syndrome. The cause of death was not known until aut-
opsy revealed metastatic carcinoma of the breast. In
each of these cases, at autopsy, the livers on gross exam-
ination were homogeneous, firm, tan-yellow in color-
ation, and contained no large metastatic lesions.
However, microscopically, poorly differentiated carcin-
oma had diffusely infiltrated hepatic sinusoids. This is a
similar presentation to our first case, although our pa-
tient had lobular breast cancer, which has the propensity
of being radiographically occult. Graber et al. reported
another case of radiographic occult breast cancer involv-
ing the liver that upon biopsy was also found to be
E-cadherin-negative [2]. Martelli et al. described the case
of a 53-year-old woman who presented with rapid pro-
gressive liver failure 4 years after treatment with chemo-
therapy and radiation for carcinoma of the breast.Radiographic imaging showed only an enlarged liver
without any metastatic lesions, but on autopsy, the liver
was found to have massive neoplastic infiltration consist-
ent with her malignancy [3]. Likewise, Goswami et al.
reported three cases of radiographic occult breast cancer
causing acute hepatic failure [4]. Nazario et al. have
done the most extensive clinical summary of this entity
involving breast cancer [5]. These authors report that in
acute liver failure caused by metastatic breast cancer, the
most common histologic finding is widespread intrasinu-
soidal infiltration of the tumor with extensive fibrous tis-
sue, driven by a desmoplastic response in some cases.
Intravascular invasion and thrombus formation impact-
ing tissue perfusion probably facilitates hepatic necrosis
commonly seen in these cases. Involvement of between
80 and 90% of hepatic parenchyma by the tumor is
thought to lead to jaundice and liver failure. Similarly,
two cases of radiographic occult neuroblastoma in
infants have been reported, where tumor cells did not
form discrete tumor masses, but on light microscopy were
observed to infiltrate hepatic sinusoids [6]. Transitional
cell carcinoma of the bladder has also been observed to
diffusely infiltrate hepatic sinusoids as described by Lanzas
Prieto [7] where ultrasound and CT imaging did not re-
veal nodules but rather heterogeneous areas in the liver.
This patient succumbed to acute liver failure shortly after
presentation; on autopsy, this patient was noted to have
an enlarged liver without any nodules, and for whom mi-
croscopy revealed hepatic sinusoid infiltration by transi-
tional cell carcinoma of the bladder. Alcalde [8] described
a similar case of a 69-year-old man with a history of trea-
ted urothelial carcinoma who had presented with upper
gastrointestinal (GI) bleeding. He then developed acute
liver failure and died 20 days after initial presentation. In
this case, imaging also failed to reveal liver lesions, but a
postmortem liver biopsy again showed infiltration of hep-
atic sinusoids by urothelial cell carcinoma, consistent with
other clinical cases discussed in this report.
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cell lung cancer (SCLC) that resulted in fulminant hep-
atic failure (FHF) [9]. Imaging by both CT and MRI of
the abdomen showed marked, rapidly progressing hep-
atomegaly; however, no nodular lesions were visible in
the liver, similar to Case 2. At autopsy, there was almost
complete parenchymal replacement with metastatic
tumor in the liver. Furthermore, these cases also high-
light the important point that neoplastic involvement of
the liver should be considered in the differential diagno-
sis of rapid hepatic enlargement with or without FHF of
unknown etiology. Gilbert et al. reported an almost
identical clinical scenario with another patient who pre-
sented with diffuse radiographic occult hepatic involve-
ment that led to the rapid death of the patient without a
definitive diagnosis [10]. At autopsy, the patient’s liver
was grossly enlarged and weighed 5200g. It was slightly
nodular and mottled in appearance but not cirrhotic.
Bilirubin congestion and fatty changes were present, but
the ducts were patent. Diffuse, white pinpoint plaques
were noted throughout the parenchyma and by light mi-
croscopy were found to contain massive and diffuseinfiltration by metastatic SCLC with concurrent hepatic
necrosis.
Another case of occult SCLC involvement of the liver
resulting in FHF was reported by Rajvanshi [11]. As with
the previously described cases, this patient, at autopsy,
was found to have on gross examination an enlarged
liver weighing 3400g with a ‘salt and pepper’ distribution
of metastases and no evidence of normal liver paren-
chyma. By light microscopy, few hepatocytes were noted
and near-complete parenchyma replacement with meta-
static small cell carcinoma, undifferentiated oat cell,
bronchogenic type, was observed. Rajvanshi also
reported a case of lymphoma involvement of the liver
that was also radiographically occult and resulted in
rapid patient death from hepatic failure [11]. Similarly,
Kim et al. and Trudel et al. found that lymphoma can
occur primarily in the liver, and in roughly 10% of these
cases, it is radiographically occult and not detected until
a biopsy is performed [12,13].
In Nascimento [14], a 59-year-old otherwise healthy
man presented initially with expressive aphasia and vis-
ual field deficits and was subsequently diagnosed with
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to have renal cell carcinoma and underwent right neph-
rectomy. At that time, his liver appeared normal on im-
aging. However, he was admitted a year later for
worsening renal function with elevation in hepatic
enzymes. Imaging via ultrasound showed a heteroge-
neous, although enlarged, liver. There was increased sig-
nal of the entire liver noted on MRI. Subsequently, the
patient underwent exploratory laparotomy where gross
examination by the surgeon failed to reveal evidence of
malignancy; however, biopsy of the liver showed meta-
static renal cell carcinoma. Shan [15] describes a case of
diffuse liver infiltration by melanoma of unknown pri-
mary origin in a 62-year-old woman who presented with
hepatomegaly and ascites; her CT and MRI scans
demonstrated hepatomegaly without any focal lesions.
She had a comprehensive workup for malignancy.
Finally, subsequent liver biopsy, as her prior extensive
workup was unrevealing, was found to contain intrasinu-
soidal infiltration by malignant melanoma cells with an
unknown primary.
When hepatic involvement occurs with tumors, the
degree of hepatic enzyme elevation varies upon presen-
tation, but is often found to correlate with the degree of
intrasinusoidal hepatic involvement. In severe cases with
rapidly growing tumors, patients can present with FHF
and subsequent multisystem organ failure as a result of
homogenous infiltration of the liver by metastatic dis-
ease. Shakir [16] presented a case of metastatic prostate
adenocarcinoma in which a 68-year-old man presented
with FHF. An abdominal CT scan revealed hepatomegaly
without focal lesions, and Doppler ultrasound showed
hepatomegaly and hepatic steatosis. The patient’s condi-
tion rapidly declined, with multiorgan system failure
necessitating emergent ICU interventions. Autopsy
revealed an enlarged liver weighing 3478g, with the bi-
opsy showing intravascular and intraparenchymal wide-
spread metastatic prostatic adenocarcinoma.
Common to all of these cases is that both CT and MRI
imaging failed to diagnose metastatic disease, as no
discrete masses or focal lesions were readily identifiable.
In all instances, a biopsy was necessary to confirm the
diagnosis of infiltrative metastatic disease. This is im-
portant because FHF is frequently caused by etiologies
other than cancer: typically, and in the majority of
patients, by viral hepatitis or drug toxicities. In 20% to
40% patients with FHF, no cause is determined, despite
extensive exhaustive workup. As liver transplantation
can provide long-term benefit for patients, it is import-
ant to reach a definitive diagnosis and identify the cause,
since liver transplantation is contraindicated in malig-
nant infiltration of the liver because these patients will
develop further metastatic disease after transplantation
[17]. Rojter et al. provided a testament to this situationin their review, where three patients were referred for
liver transplantation after negative radiographic workup
via CT and ultrasound for liver failure. In each case, be-
fore or after liver transplantation, biopsy revealed that
each case had vascular tumors present in the liver, either
angiosarcoma or hemangioendothelioma [18]. In these
cases, where vascular tumors were involved, MRI can
help with the diagnosis, as two of the three cases were
suspected to have tumor burden in the liver after MRI
imaging. Radiographically undetected involvement of ab-
dominal organs, including the liver, is not uncommon
with many different tumor types, as summarized in
Table 1. Winkelmann [19] conducted a correlation study
of abdomen CT imaging with autopsy findings in
patients with malignant tumors, finding that CT scans
missed between 5 and 10% of metastatic lesions. This is
confirmed in this report, as breast cancer, lung cancer,
and sarcomas can massively involve the liver but remain
radiographically occult. Unfortunately for many of these
patients, these critical biopsies and subsequent diagnosis
had to await postmortem examination, given the rapid
progression of malignancy resulting in death. This may
be inconsequential, as this overwhelming tumor involve-
ment of the liver is inevitably fatal.
Conclusion
This case series highlights the not-infrequent occurrence
of radiographic occult cancers in the liver that can
present to both the family medicine practitioner and the
seasoned oncologist.
Experience and familiarity with this type of presenta-
tion can foster the necessary high index of clinical suspi-
cion that can prevent misdiagnosis in patients who
present with hepatomegaly, occult hepatic insufficiency,
or rapidly progressing pain without an obvious explan-
ation. If this type of presentation is initially recognized, a
diagnostic biopsy can quickly occur and help overcome
the clinical hesitation to biopsy a swollen and enlarged
liver. It also helps avoid the need for an autopsy, which
unfortunately is all too common, as demonstrated by
our literature review, where many diagnoses were only
made postmortem. Moreover, not deferring or delaying a
diagnostic biopsy can prevent undue clinical deterior-
ation due either to the rapid progression of the un-
treated cancer or the cancer’s associated morbidity, such
as GI bleeding, leading to prolonged hospital stays and
admission to the ICU. Since aggressive treatment-based
options are often poorly tolerated and ineffective in such
cases, transition to an outpatient palliative approach
and comfort care is often warranted, as evidenced in
Case 2, if pain control can be achieved. In summary,
then, quick recognition of this diagnosis and confirma-
tory biopsy will usually lead to the best available out-
come for the patient.
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